Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone acetonide dissolving microneedle patch for hypertrophic scar and keloid
TCTR20220318004Phase 2Enrolling by invitation
- Sponsor
- Division of Dermatology, Department of internal medicine, Faculty of medicine, Thammasat University
- Start
- Feb 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triamcinolone acetonide in Hypertrophic Scar (HS), keloid, sponsored by Division of Dermatology, Department of internal medicine, Faculty of medicine, Thammasat University. Started Feb 2021; status: enrolling by invitation.
02
Drugs
triamcinolone acetonide
03
Conditions
Hypertrophic Scar (HS)keloid
Beyond the preview
Go deeper on TCTR20220318004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220318004.